Latest / Stock Movers / Galderma Slumps, AB Foods Falls, CMC Markets Soars
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look now at some of the stocks
- 0:18Speaker 3: on the move today, and you know, I'm James Wilcock
- 0:19Speaker 3: with Carolin Hepka and we are joined as ever by
- 0:22Speaker 3: Bloomberg's Breaking News up to seth Louise Moon.
- 0:24Speaker 1: Louise, let's start with AB Foods.
- 0:27Speaker 3: Investors seem to be having a bit of a downturn
- 0:29Speaker 3: this morning. What's going on?
- 0:31Speaker 4: Yeah, andds A shares fell this morning by the most
- 0:33Speaker 4: in over two months, so that makes it one of
- 0:35Speaker 4: the worst performers on the foot seat one hundred. This
- 0:38Speaker 4: is after a third quarter update by ABE Foods, and
- 0:42Speaker 4: obviously this comes ahead of Abe food splitting into two units.
- 0:46Speaker 4: It's splitting into food and clothing units, so to take
- 0:48Speaker 4: those two units as separate points. So clothing, which essentially
- 0:51Speaker 4: primark sales fell. They blamed what they called a challenging
- 0:56Speaker 4: retail environments. There's a lot of competition from other online
- 0:59Speaker 4: foss fashion giants like the like Sashian and so on,
- 1:02Speaker 4: and they're looking food, which is essentially sugar. They have
- 1:07Speaker 4: cut that outlook for the sugar business for twenty twenty
- 1:09Speaker 4: six and twenty twenty seven, contending with a whole host
- 1:13Speaker 4: of things, so higher gas prices on the back of
- 1:15Speaker 4: the war, rising fuel and fertilizer costs as well.
- 1:19Speaker 1: European sugar prices are also.
- 1:20Speaker 4: Falling, and they're saying that this outlook and this cut
- 1:23Speaker 4: of the outlook also hinges on or assumes a wide
- 1:27Speaker 4: variety of things, so including no currency devaluation in Malawi.
- 1:33Speaker 4: It also hinges on El Nino because they've got factory
- 1:35Speaker 4: in Tanzania, so a whole range of things that they're
- 1:38Speaker 4: really contending with their so analysts calling it a disappointing update.
- 1:42Speaker 4: You could see that AB Foods kind of try to
- 1:44Speaker 4: reassure by keeping their overall guidance intact despite cutting the
- 1:47Speaker 4: outlook for sugar. But sugar is really what's being focused on,
- 1:51Speaker 4: and that's why shares are falling so heavily this morning.
- 1:53Speaker 1: Yeah, very difficult with that commodities business, isn't it now?
- 1:56Speaker 1: A slump for the dermatology for galderma? Are they in
- 2:02Speaker 1: a spot of bother?
- 2:04Speaker 4: Well, potentially shares dropped as much as over six percent
- 2:07Speaker 4: this morning. So, as you say, they're the dermatology company
- 2:11Speaker 4: in Switzerland. The US FDA, so the regulator has declined
- 2:14Speaker 4: to approve one of their treatments. This is a rival
- 2:17Speaker 4: botox treatment, so arrival to Abbib's treatments. So the difference
- 2:22Speaker 4: is that Galdermas they say that the effects will last
- 2:25Speaker 4: longer and it also comes ready to use, but this
- 2:30Speaker 4: has been declined in the US at the moment. Essentially,
- 2:34Speaker 4: the US regulator has made observations about things that needs
- 2:36Speaker 4: to change, and Galderma is putting in place corrective and
- 2:40Speaker 4: preventative actions in response to that. But it's not the
- 2:45Speaker 4: first time they face issues with approval in the US.
- 2:48Speaker 1: The product has already been rejected.
- 2:50Speaker 4: It was rejected in twenty twenty three due to some
- 2:53Speaker 4: unrelated deficiencies. Those were related to chemicals, manufacturing, controls processes.
- 3:00Speaker 4: Unless that Jeffreyes was saying, you know, it's not desirable,
- 3:02Speaker 4: but it's not too surprising given that it was rejected
- 3:04Speaker 4: in twenty twenty three, and they are, as I say,
- 3:07Speaker 4: making changes. So Jefferies is saying about a nine to
- 3:10Speaker 4: twelve month delay to approval, but still shares dropping as
- 3:14Speaker 4: much as over six percent.
- 3:15Speaker 3: And finally, CMC Markets this morning are talking about strong momentum.
- 3:19Speaker 3: I'm packed that for us.
- 3:20Speaker 4: Indeed, yes, this is the online trading platform. They raised
- 3:23Speaker 4: their profit guidance for the year, saying continued momentum for
- 3:27Speaker 4: its B to B arm. So analyst is saying, you
- 3:30Speaker 4: know that this update is kind of further validation for
- 3:33Speaker 4: investments that CMC have made into the B to business
- 3:36Speaker 4: in recent years, and as a result of this upgrade
- 3:40Speaker 4: today that their stock has kind of rerating potential on
- 3:43Speaker 4: the back of this. It's the second time they've upgraded
- 3:45Speaker 4: guidance this year. Shares surged this morning to record high
- 3:49Speaker 4: as much as twenty three percent, and it takes gains
- 3:51Speaker 4: for the whole year to about eighty eight percent.
- 3:53Speaker 1: So a strong update there from CMC Markets.
- 3:57Speaker 2: The Stock Movers report from bloom Radio. Check back with
- 4:01Speaker 2: us throughout the day for the latest roundup of companies
- 4:04Speaker 2: making news on Wall Street and for the latest market
- 4:07Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:12Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:15Speaker 2: the Bloomberg Business app.